Your session is about to expire
← Back to Search
Behavioural Intervention
Error-enhanced Learning for Stroke Recovery
N/A
Recruiting
Led By James Patton, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
Hemiparesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60-90 minutes
Awards & highlights
Study Summary
This trial is testing a new way to improve movement ability for people who have had a stroke, by designing exercises specifically to address their individual movement errors.
Who is the study for?
This trial is for adults over 18 who have had a stroke at least 8 months ago, affecting the primary motor cortex but still retain some shoulder and elbow movement. It's not suitable for those with severe medical issues, recent Botox in the arm, bilateral paresis, multiple strokes or lesions, severe sensory deficits, high spasticity preventing movement, cognitive impairments that affect task performance or those already in upper extremity rehab.Check my eligibility
What is being tested?
The study tests how making mistakes during exercises can help improve arm function after a stroke. Participants will reach for targets using their affected arm while researchers track errors to tailor an exercise program aimed at enhancing recovery based on individual error patterns.See study design
What are the potential side effects?
Since this intervention involves physical exercises tailored to each participant's abilities and error patterns rather than medication or invasive procedures, side effects are minimal but may include muscle soreness or fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stroke over 8 months ago affecting my movement control area.
Select...
I have weakness on one side of my body.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60-90 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60-90 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Perpendicular Error
Secondary outcome measures
Action Research Arm Test
Other outcome measures
Box and Blocks
Upper Extremity portion of the Fugl-Meyer
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group 2Experimental Treatment2 Interventions
Group II: Group 1Experimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
192 Previous Clinical Trials
14,865 Total Patients Enrolled
69 Trials studying Stroke
6,325 Patients Enrolled for Stroke
James Patton, PhDPrincipal InvestigatorShirley Ryan AbilityLab
2 Previous Clinical Trials
60 Total Patients Enrolled
2 Trials studying Stroke
60 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe health issues right now.I have weakness in both sides of my body.You have participated in a similar study involving robotics before.I have severe difficulty sensing body position and movement.I do not have vision problems that stop me from seeing things to my side.I have had multiple strokes or have several areas affected by stroke.I cannot stay in certain positions for tests.I have received a Botox injection in my arm within the last 4 months.I had a stroke over 8 months ago affecting my movement control area.I do not have speech, thinking, or mood problems that would affect my participation.I have weakness on one side of my body.I am currently participating in an upper extremity rehabilitation program.I am 18 years old or older.You have trouble feeling things when touched with two points (the distance between the points must be less than 11mm).My severe muscle stiffness hinders my movement.I can move both my shoulders and elbows.I have other neurological conditions.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1
- Group 2: Group 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants can this experiment accommodate?
"Affirmative. According to the clinicaltrials.gov webpage, this research initiative is still recruiting individuals for participation; it was initially posted on May 1st 2022 and updated most recently on April 19th 2022. A total of 20 participants are being sought from a solitary medical site."
Answered by AI
Are there any vacancies within this research endeavor?
"According to the available information, this clinical trial is currently seeking participants. It was initially published on May 1st 2022 and its most recent update occurred on April 19th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger